Revolutionizing QRM: The Impact of AI and ML

In the podcast episode, Merck and Co. Executive Director Ghada Haddad discusses AI and ML and their potential impact on the pharma industry. Haddad was the chair of the PDA Paradigm Change in Manufacturing (PCMO) initiative co-chaired the Aging Facilities Points to Consider, co-chaired the PDA Annual Meeting, and was a previous member of the Science Advisory Board and the PDA Board of Directors. In addition, Haddad is currently the Associate Editor of the PDA Journal Pharmaceutical Science and Technology.